Female Genital Schistosomiasis in Migrant Women: A Pilot Study

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Feb 10, 2025

Keywords

ClinConnect Summary

The "GynoBizh" study is looking into a condition called female genital schistosomiasis (FGS), which is caused by a parasite and can affect women, especially those from certain regions in Africa. This pilot study will focus on migrant women from sub-Saharan Africa who are living in countries where this disease is not common. Researchers want to understand how often FGS occurs and what its symptoms look like by examining women and conducting tests over the course of a year. The goal is to improve diagnosis and care for women who may be affected by this condition.

To be part of this study, women aged 25 to 65 who were born in areas where schistosomiasis is common and have tested positive for the parasite are eligible. Participants will undergo gynecological exams and other tests to check for any genital lesions related to FGS. The study is not yet recruiting participants, but it aims to help improve health outcomes for women in underserved communities. If you or someone you know fits the criteria and is interested, they could play a valuable role in advancing our understanding of this condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 25 to 65 years
• • Born in a schistosomiasis-endemic area in sub-Saharan Africa
• • With a positive serology by Schistosoma spp. Western Blot
• Exclusion Criteria:
• • Refusal to participate in the study
• • Patient unable to provide consent
• • Patient under guardianship or trusteeship
• • Patient who is a virgin at the time of selection
• • Patient who is pregnant at the time of selection